Veeva Systems Total Cost of Revenue increased by 7.0% to $213.48M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.9%, from $180.99M to $213.48M. Over 4 years (FY 2022 to FY 2026), Total Cost of Revenue shows an upward trend with a 11.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $116.14M | $122.10M | $129.56M | $135.88M | $139.52M | $151.67M | $153.91M | $164.31M | $166.66M | $169.02M | $167.68M | $173.93M | $173.88M | $170.37M | $174.39M | $180.99M | $173.82M | $195.25M | $199.47M | $213.48M |
| QoQ Change | — | +5.1% | +6.1% | +4.9% | +2.7% | +8.7% | +1.5% | +6.8% | +1.4% | +1.4% | -0.8% | +3.7% | -0.0% | -2.0% | +2.4% | +3.8% | -4.0% | +12.3% | +2.2% | +7.0% |
| YoY Change | — | — | — | — | +20.1% | +24.2% | +18.8% | +20.9% | +19.5% | +11.4% | +9.0% | +5.9% | +4.3% | +0.8% | +4.0% | +4.1% | -0.0% | +14.6% | +14.4% | +17.9% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Professional services and other | $95.74M | $91.58M | $91.75M | $97.50M | $95.48M | $101.42M | $105.29M | $116.94M |
| Subscription | $78.15M | $78.79M | $82.64M | $83.49M | $78.35M | $93.83M | $94.17M | $96.54M |
| Total | $173.88M | $170.37M | $174.39M | $180.99M | $173.82M | $195.25M | $199.47M | $213.48M |